Brief: Nautilus Biotechnology - Net Loss $14.7 Million For Q2 Of 2022, Versus Net Loss Of $10.7 Million For Corresponding Prior Year Period
Aug 2 (Reuters) - Nautilus Biotechnology Inc NAUT.O :
* NAUTILUS BIOTECHNOLOGY - NET LOSS $14.7 MILLION FOR Q2 OF
2022,
VERSUS NET LOSS OF $10.7 MILLION FOR CORRESPONDING PRIOR YEAR
PERIOD
* NAUTILUS BIOTECHNOLOGY INC - CASH, CASH EQUIVALENTS, AND
INVESTMENTS WERE $334.9 MILLION AS OF JUNE 30, 2022
Further company coverage: NAUT.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Nautilus Biotechnology
See all newsNautilus Biotechnology, Inc. expected to post a loss of 14 cents a share - Earnings Preview
Brief: Nautilus Biotechnology May Offer Up To $300 Million Of Securities - SEC Filing
Nautilus Biotechnology Inc reports results for the quarter ended June 30 - Earnings Summary
Nautilus Biotechnology posts first revenue, Q2 net loss narrows
Brief: Nautilus Biotechnology Q2 EPS USD -0.11